BCTXZ BriaCell Therapeutics Corp. - Warrant
$0.11
Price · May 19, 2026
Fundamentals as of Mar 10, 2026
52W Range
$0–$0
16% of range
Analyst Rating
—
Price Target
—
P/E (TTM)
—
ROE
-255.9%
Net Profit Margin
—
BCTXZ Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.11
Market Cap
—
P/E (TTM)
—
EPS (TTM)
$-62.19
Revenue (TTM)
—
Div Yield
—
ROE
-255.9%
Debt/Equity
—
52W Range
$0 – $0
BCTXZ Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
$-62.19
2022-07-31
→
2025-07-31
Free Cash Flow
—
2024-07-31
→
2024-07-31
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
BCTXZ
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
BCTXZ
Peer Median
ROA
-191.2%
—
ROE
-255.9%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
BCTXZ
Peer Median
Current Ratio
5.0
—
Quick Ratio
4.5
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
BCTXZ
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
BCTXZ
Peer Median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 14
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $21M | $27M | $15M | $8M | $2M | |
| SG&A Expense | $6M | $6M | $8M | $7M | $5M | |
| Operating Expenses | $27M | $33M | $23M | · | · | |
| Operating Income | $-27M | $-33M | $-23M | $-15M | $-7M | |
| Interest Expense | · | · | · | $979 | $78.6K | |
| Interest Income | $120.0K | $288.0K | $891.2K | $136.7K | $3.1K | |
| Other Non-op | $114.5K | $262.6K | $850.3K | $-12M | $-7M | |
| Pretax Income | $27M | $5M | $20M | $-27M | $-14M | |
| Net Income | $-26M | $-5M | $-20M | $-27M | $-14M | |
| EPS (Basic) | $-62.19 | $-43.68 | $-1.30 | $-1.73 | $-3.06 | |
| EPS (Diluted) | $-62.19 | $-43.68 | $-1.30 | $-1.73 | · | |
| Shares (Basic) | 423,114 | 109,699 | 15,619,676 | 15,494,091 | 4,519,579 | |
| Shares (Diluted) | 423,114 | 109,699 | 15,619,676 | 15,494,091 | · | |
| EBITDA | $-27M | $-33M | $-23M | $-15M | · |
Balance Sheet 17
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $862.1K | $21M | $41M | $57M | |
| Short-term Investments | $7M | · | · | · | · | |
| Receivables | · | · | $18.9K | $24.1K | $12.6K | |
| Prepaid Expense | $1M | $1M | $5M | $1M | $516.9K | |
| Current Assets | $20M | $4M | $27M | $42M | $58M | |
| PP&E (Net) | $296.8K | $388.2K | · | $2.5K | · | |
| PP&E (Gross) | · | $456.8K | · | · | · | |
| Intangibles | $184.5K | $199.8K | $215.1K | $230.3K | $245.6K | |
| Total Assets | $22M | $6M | $27M | $43M | $58M | |
| Current Liabilities | $4M | $7M | $2M | $941.1K | $556.8K | |
| Common Stock | $102M | $72M | $70M | $66M | $55M | |
| Paid-in Capital | · | · | $7M | · | · | |
| Retained Earnings | $-112M | $-85M | $-81M | $-60M | $-29M | |
| AOCI | $-138.7K | $-138.7K | $-138.7K | $-138.7K | $-138.7K | |
| Stockholders' Equity | $17M | $-3M | $-4M | $10M | $28M | |
| Liabilities + Equity | $22M | $6M | $27M | $43M | $58M | |
| Shares Outstanding | 1,883,906 | 121,907 | 15,981,726 | 15,518,018 | 15,269,583 |
Cash Flow 12
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| D&A | · | · | · | $15.3K | $15.3K | |
| Stock-based Comp | $776.9K | $2M | $2M | $3M | $2M | |
| Amort. of Intangibles | $15.3K | $15.3K | $15.3K | $15.3K | $15.3K | |
| Other Non-cash | · | · | · | $11M | · | |
| Operating Cash Flow | $-28M | $-24M | $-24M | $-12M | $-8M | |
| CapEx | · | $456.8K | · | · | · | |
| Investing Cash Flow | $-8M | $-681.8K | · | · | · | |
| Stock Issued | $45M | $4M | $4M | · | · | |
| Net Stock Activity | $45M | $4M | $4M | · | · | |
| Financing Cash Flow | $45M | $4M | $4M | $-4M | $65M | |
| Net Change in Cash | $10M | $-20M | $-20M | · | · | |
| Free Cash Flow | · | $-25M | · | · | · |
Profitability 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ROA | -191.2% | -29.0% | -58.2% | -53.3% | · | |
| ROE | -255.9% | 107.5% | 419.9% | -264.6% | · |
Liquidity & Solvency 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 0.5 | 15.0 | 45.0 | · | |
| Quick Ratio | 4.5 | 0.1 | 11.8 | 43.6 | · | |
| Interest Coverage | · | · | · | -15616.9 | · |
Valuation (TTM) 1
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-26M | $-5M | $-20M | $-27M | · |
Income Statement 13
| Metric | Trend | Q2 2026 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2024 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2023 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2022 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $6M | $7M | $7M | $5M | $6M | $4M | $4M | $8M | $8M | $7M | $5M | $4M | $3M | $3M | $3M | |
| SG&A Expense | $1M | $2M | $1M | $2M | $1M | $1M | $1M | $2M | $2M | $2M | $3M | $2M | $1M | $2M | $2M | |
| Operating Expenses | $8M | $8M | $9M | $6M | $7M | $5M | $6M | $9M | $10M | $9M | $8M | $6M | $4M | $5M | · | |
| Operating Income | $-8M | $-8M | $-9M | $-6M | $-7M | $-5M | $-6M | $-9M | $-10M | $-9M | $-8M | $-6M | $-4M | $-5M | $-5M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Interest Income | $105.6K | $48.5K | $33.4K | $26.6K | $46.8K | $13.1K | $2 | $15.6K | $81.6K | $190.8K | $208.8K | $253.5K | $240.6K | $188.4K | $82.4K | |
| Other Non-op | $84.6K | $158.6K | $45.2K | $-9.8K | $67.4K | $11.7K | $-12.1K | $13.2K | $81.6K | $179.8K | $3M | $781.6K | $-7M | $4M | $5M | |
| Net Income | $-7M | $-8M | $-8M | $-6M | $-6M | $-6M | $-1M | $2M | $-11M | $6M | $-2M | $-5M | $-12M | $-1M | $-450.4K | |
| EPS (Basic) | $-2.58 | $-4.35 | $-4.57 | $-1.64 | $-23.31 | $-32.67 | $-35.03 | $1.61 | $-10.64 | $0.38 | $-0.14 | $-0.32 | $-0.77 | $-0.07 | · | |
| EPS (Diluted) | $-2.58 | $-4.35 | $-4.57 | $-1.64 | $-23.31 | $-32.67 | $-34.15 | $1.61 | $-10.64 | $-0.50 | $-0.14 | $-0.32 | $-0.77 | $-0.07 | $-0.03 | |
| Shares (Basic) | 2,802,337 | 1,883,906 | -3,759,966 | 3,735,517 | 269,957 | 177,606 | -18,002,923 | 1,065,448 | 1,065,448 | 15,981,726 | -30,934,432 | 15,518,072 | 15,518,018 | 15,518,018 | -30,892,329 | |
| Shares (Diluted) | 2,802,337 | 1,883,906 | -3,759,966 | 3,735,517 | 269,957 | 177,606 | -18,696,088 | 1,065,448 | 1,065,448 | 16,674,891 | -30,934,432 | 15,518,072 | 15,518,018 | 15,518,018 | 8,063 | |
| EBITDA | $-8M | $-8M | · | $-6M | $-7M | $-5M | · | $-9M | $-10M | $-9M | · | $-6M | $-4M | $-5M | · |
Balance Sheet 17
| Metric | Trend | Q2 2026 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2024 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2023 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2022 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $3M | $10M | $12M | $5M | $6M | $862.1K | $935.7K | $6M | $14M | $21M | $28M | $34M | $37M | $41M | |
| Short-term Investments | · | $7M | $7M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables | · | · | · | · | · | · | · | $15.2K | $30.1K | $21.4K | · | $14.9K | $8.9K | $29.7K | $24.1K | |
| Prepaid Expense | · | · | $1M | · | · | · | $1M | $5M | $5M | $5M | $5M | $1M | $429.4K | $742.1K | $1M | |
| Current Assets | $32M | $11M | $20M | $15M | $7M | $8M | $4M | $6M | $12M | $18M | $27M | $30M | $34M | $38M | $42M | |
| PP&E (Net) | $251.1K | $274.0K | $296.8K | $319.7K | $342.5K | $365.3K | $388.2K | · | · | · | · | · | · | · | · | |
| PP&E (Gross) | · | · | · | · | · | · | $456.8K | · | · | · | · | · | · | · | · | |
| Intangibles | · | $180.7K | $184.5K | $188.3K | $192.2K | $196.0K | $199.8K | $203.6K | $207.4K | $211.2K | $215.1K | $218.9K | $222.7K | $226.5K | $230.3K | |
| Total Assets | $34M | $13M | $22M | $17M | $9M | $10M | $6M | $6M | $12M | $19M | $27M | $30M | $34M | $38M | $43M | |
| Current Liabilities | $3M | $3M | $4M | $4M | $5M | $5M | $7M | $7M | $4M | $1M | $2M | $1M | $670.4K | $974.0K | $941.1K | |
| Common Stock | $117M | $102M | $102M | $94M | $85M | $82M | $72M | $70M | $70M | $70M | $70M | $66M | $66M | $66M | $66M | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | $8M | · | · | · | · | · | |
| Retained Earnings | $-127M | $-120M | $-112M | $-104M | $-98M | $-91M | $-85M | $-84M | $-86M | $-75M | $-81M | $-78M | $-73M | $-61M | $-60M | |
| AOCI | $-138.7K | $-138.7K | $-138.7K | $-138.7K | $-138.7K | $-138.7K | $-138.7K | $-138.7K | $-138.7K | $-138.7K | $-138.7K | $-138.7K | $-138.7K | $-138.7K | $-138.7K | |
| Stockholders' Equity | $30M | $9M | $17M | $12M | $3M | $4M | $-3M | $-6M | $-8M | $3M | $-4M | $-6M | $-1M | $10M | $10M | |
| Liabilities + Equity | $34M | $13M | $22M | $17M | $9M | $10M | $6M | $6M | $12M | $19M | $27M | $30M | $34M | $38M | $43M | |
| Shares Outstanding | 7,250,487 | · | 1,883,906 | 6,558,092 | 2,946,940 | 36,183,161 | 121,907 | 15,981,726 | 15,981,726 | 15,981,726 | 15,981,726 | 15,518,318 | 15,518,018 | 15,518,018 | 15,518,018 |
Cash Flow 9
| Metric | Trend | Q2 2026 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2024 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2023 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2022 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $26.7K | · | · | · | $3.8K | $3.8K | $3.8K | · | $3.8K | $3.8K | $3.8K | · | |
| Stock-based Comp | $285.9K | $294.7K | $0 | $224.8K | $285.1K | $267.0K | $377.9K | $392.2K | $500.2K | $533.8K | $533.8K | $281.2K | $266.8K | $1M | $877.9K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | $-4M | · | |
| Operating Cash Flow | $-8M | $-8M | $-8M | $-7M | $-6M | $-7M | $-4M | $-5M | $-7M | $-8M | $-11M | $-5M | $-4M | $-4M | $-3M | |
| Investing Cash Flow | $7M | $-75.0K | $-7M | $-105.0K | $-75.0K | $-75.0K | $-456.8K | · | · | · | · | · | · | · | · | |
| Stock Issued | · | · | $14M | $15M | $5M | $12M | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $12M | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | · | · | $14M | $15M | $5M | $12M | · | · | · | · | $4M | $1.6K | $0 | $-47.3K | $-159.8K | |
| Net Change in Cash | $27M | $-8M | $-2M | $7M | $-778.6K | $5M | $-73.6K | $-5M | $-7M | $-8M | $-7M | · | · | · | · |
Profitability 2
| Metric | Trend | Q2 2026 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2024 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2023 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2022 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -33.6% | -69.8% | · | -52.8% | -58.3% | -40.0% | · | 9.6% | -48.7% | 21.0% | · | -32.9% | -69.6% | -5.8% | · | |
| ROE | -43.2% | -125.5% | · | -214.7% | 247.2% | -186.3% | · | -28.3% | 235.3% | 93.4% | · | 166.2% | 1855.7% | -21.4% | · |
Liquidity & Solvency 2
| Metric | Trend | Q2 2026 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2024 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2023 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2022 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.1 | 3.4 | · | 3.4 | 1.4 | 1.6 | · | 0.8 | 3.0 | 17.6 | · | 21.3 | 50.6 | 39.2 | · | |
| Quick Ratio | 9.4 | 3.1 | · | 2.9 | 1.0 | 1.2 | · | 0.1 | 1.6 | 13.1 | · | 20.4 | 50.0 | 38.5 | · |
Valuation (TTM) 1
| Metric | Trend | Q2 2026 | Q1 2025 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2024 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2023 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2022 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-28M | $-26M | · | $-17M | $-22M | $-9M | · | $-8M | $-22M | $-12M | · | $-28M | $-12M | $-27M | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 | |
|---|---|---|---|---|---|
| Net Income | $-26M | $-5M | $-20M | $-27M | $-14M |
| Diluted EPS | $-62.19 | $-43.68 | $-1.30 | $-1.73 | — |
Balance Sheet
| 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 | |
|---|---|---|---|---|---|
| Current Ratio | 5.0 | 0.5 | 15.0 | 45.0 | — |
| Quick Ratio | 4.5 | 0.1 | 11.8 | 43.6 | — |
Cash Flow
| 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | — | $-25M | — | — | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.